Injured? Call For A Free Consultation

Call Us
E-Mail Us

Dangerous Drugs Lawyers

Not every FDA approved drug is safe for you. dangerous drugs lawyers have decades of experience handling lawsuits involving defective drugs.

Prempro

Prempro was introduced in the mid 1990s and marketed towards women for hormone replacement therapy. The Food and Drug Administration (FDA) approved the pharmaceutical product for short term treatment of hot flashes and other symptoms experienced by women during the beginning stages of menopause.

In containing a mixture of estrogen and progestin, Prempro is designed to compensate for low hormone levels in women who are coping with menopause, which lowers a woman’s ability to produce estrogen and progesterone. This sudden alteration in hormone levels contributes to night sweats, mood changes, hot flashes, insomnia, and diminished sex drive. In being marketed as an effective form of hormone replacement therapy to alleviate menopause symptoms, many women have turned to Prempro, trusting that the product would not cause them any harm. However, several lawsuits have been filed against the makers of Prempro, Wyeth Pharmaceuticals, for serious side effects that have been devastating to some women’s health.

Serious Prempro Side Effects and Marketing Misrepresentation

A vast federal study in 2002 showed that the risks of Prempro long term use significantly outweigh its benefits. Some of the most serious side effects associated with long term use of Prempro include a high risk of developing breast or ovarian cancer, heart disease, blood clots, or stroke. The defective drug has also been linked to causing abnormal mammograms.

Not only has Prempro put women’s lives at risk, but the drug was promoted as a “cure all” product for older women for uses that were not approved by the FDA. Several articles were submitted to medical journals by Wyeth-hired ghost writers claiming that Prempro could prevent heart disease, osteoporosis, Alzheimer’s, and treat depression, as well as renew sex drive. In marketing these unfounded claims, it was shortly discovered that Prempro could place the lives of many women in danger. In making elaborate claims, Wyeth made its pharmaceutical product more appealing to women, which led them to take Prempro for much longer periods than recommended by the FDA and for reasons not approved by the FDA.

Since several studies have brought the dangers of Prempro to light, several women no longer use it or have significantly altered the way in which they use the drug. Even though a lower number of women using Prempro has caused a reduction in the amount of women suffering breast cancer, several women are still coping with health problems from the drug that they trusted would help them.

Women who have experienced adverse side effects from taking Prempro may be able to seek compensation for expenses associated with their health problems. E. Ryan Bradley has decades of experience successfully handling a wide range of personal injury and product liability claims. Contact us by calling 312.252.1488 for a free consultation regarding your specific case.

Trasylol

Trasylol, also referred to in generic form as Aprotinin, was approved by the Food and Drug Administration (FDA) in 1993 to be given to patients about to have heart surgery. The medication is used to help clot a patient’s blood so that bleeding does not take place during surgery. As trusting consumers and physicians have relied on the drug, it has been determined that Trasylol may cause a person’s kidney(s) to stop functioning normally, or altogether, and may even lead to a patient’s death. defective product attorney E. Ryan Bradley continues to investigate this potentially harmful pharmaceutical in-depth and is presently helping individuals who are seeking compensation from Trasylol manufacturer Bayer Pharmaceuticals. Trasylol has been at the forefront of class action lawsuits in many other states for being shown to lead to post surgery kidney breakdown and a 64% increased possibility of mortality.

Trasylol Side Effect Studies

In an objective study of 10,000 patients having heart surgery between 1996 and 2005, Duke University Medical Center researchers discovered that patients who were given Trasylol were more prone, by 6.5%, to lose their life as soon as 30 days after having surgery than patients who were given a different blood clotting drug. Similarly, another team of researchers observed 78,000 patients from 2003 to 2006 and discovered that the chance of fatality in patients given Trasylol was 64% greater than in patients who were given a substitute pharmaceutical. The New England Journal of Medicine even made a study available demonstrating that Trasylol was the cause of over 10,000 to 11,000 annually incidents of kidneys failing.

Many consumers and patients are shocked by these studies not only because of what they have revealed about Trasylol, but also because of the potential dangers that did not stop the Food and Drug Administration from widening the permitted use of Trasylol for all patients undergoing heart surgery in 1998. In making over 3 million dollars each year from Trasylol and projecting a rise in profit to 7.5 million dollars each year, Bayer pressured the FDA for its authorization.

Not only does Trasylol seriously endanger patients, but it is also more costly than other blood clotting medications existing for use by those undergoing heart surgery. A typical dose of Trasylol costs about $1,400. In joining the pharmaceutical’s cost with the expenses of subsequent health problems, a total of 1 billion dollars a year was calculated in the U.S. What is very shocking to heart surgery patients and the general public is that two different blood clotting medications are obtainable by heart surgery patients, Tranexamic acid and Aminocaproic acid, which equally have a price tag ranging from 50 to 100 dollars per dose and do not present nearly as many potential complications as Trasylol.

After these studies about the dangers of Trasylol became widely known, Bayer conducted a separate analysis and appointed Harvard Professor Dr. Alexander Walker to examine the records of 70,000 patients who had been given Trasylol. Just like previous results, Dr. Walker’s examination determined that Trasylol patients are placed in heightened danger of losing their life or suffering kidney failure.

After addressing the issues with Trasylol in 2006, the FDA requested in November 2007 that the drug no longer be made available for patient use. This demand was made shortly after a study in Canada had to be shut down due to Trasylol patients dying at fast rates. Approximately 1,000 patients died each month from side effects associated with Trasylol from the point when the FDA had its gathering in 2006 until their conclusion that the drug should be removed from the market in late 2007.

Patients who have experienced, or are experiencing, incapacitating kidney malfunction, health problems from stroke, or family members enduring the wrongful death of a loved one due to Trasylol have valid legal rights that deserve to be protected. If you or someone you care about has suffered serious Trasylol side effects, an Illinois personal injury lawyer can help you obtain the compensation that you deserve. The time allowed to file a Trasylol claim is limited, which is why it is crucial to act quickly in contacting an attorney with the experience that you need in pharmaceutical litigation.

Bayer Trasylol Injury Liability

Reports have shown that Bayer knew of serious Trasylol complications as early as the 1980s, yet still continued manufacturing and marketing the drug. Although Trasylol was given the FDA’s stamp of approval to be used by a limited group of patients, those undergoing heart surgery who had a high risk of bleeding, the substantial danger of the drug increased the chance that patients would suffer kidney failure and require dialysis. A top heart surgeon in the United States, Dr. Nicholas Kouchoukos, agrees with the claim that most patients endured kidney failure, permanent debilitating kidney function, and a heightened risk of heart attack and stroke.

Because Bayer repeatedly failed to properly caution consumers about the potential risks of Trasylol, Bayer is legally responsible for the life-altering consequences that its dangerous drug has imposed on trusting patients and their families. A patient may not be aware that he or she was given Trasylol until destructive health complications have already imposed significant physical, emotional, and financial challenges. Anyone who has undergone heart surgery and since endured renal failure, heart attack, or stroke may want to contact an Illinois personal injury lawyer with experience in pharmaceutical litigation to find out if Trasylol is at the root of causation.

How Our Lawyers Can Help

Defective drug attorney E. Ryan Bradley has decades of experience protecting the rights of individuals harmed in personal injury and product liability cases. Legal claims against Bayer may be warranted in regard to serious injuries, illnesses, and deaths connected to this dangerous drug. Call right away to discuss your potential case in a free consultation.

Trasylol (generic: aprotinin) was approved by the FDA in 1993 as a blood clotting drug to prevent bleeding given to patients about to undergo heart surgery. As trusting consumers and physicians have relied on the drug, it has now been connected to renal (kidney) failure and even death. E. Ryan Bradley has investigated this dangerous pharmaceutical in-depth and is currently taking on cases against its manufacturer, Bayer Pharmaceuticals. Trasylol has been the target of class action lawsuits in many other states for being shown to lead to post surgery kidney failure and a 64% increased chance of death.

Trasylol Side Effect Studies

In an independent study of 10,000 patients having heart surgery between 1996 and 2005, Duke University Medical Center researchers discovered that patients who were given Trasylol were 6.5% more likely to die within 30 days of surgery than patients who were given alternative blood clotting drugs. Similarly, another team of researchers observed 78,000 patients from 2003 to 2006 and found that the chance of death in Trasylol patients was 64% greater than in alternative drug patients. The New England Journal of Medicine even published a study stating that Trasylol was the cause for over 10,000 to 11,000 renal failure cases each year.

However, these studies that show the risks of Trasylol did not stop the FDA from expanding the approved use of the drug to include all heart surgery patients in 1998. In making over 3 million dollars a year from Trasylol and projecting an increase in profit to 7.5 million dollars a year, Bayer pressured the FDA for its approval.

Not only does Trasylol pose serious risks to patients, but it also more expensive than alternative clotting medications available to heart surgery patients. A typical dose of Trasylol costs about 1,400 dollars. In joining the pharmaceutical’s cost with the expenses of resulting health complications, a total of 1 billion dollars a year was calculated in the U.S. alone. What is very shocking to patients and the general public is that two alternative clotting drugs are available to heart surgery patients – Tranexamic acid and aminocaproic acid – that only cost 50 to 100 dollars per dose and do not present nearly as devastating side effects.

After these studies about the dangers of Trasylol became widely known, Bayer conducted its own study and hired Harvard professor Dr. Alexander Walker to examine the records of 70,000 patients having taken Trasylol. Just like previous results, Dr. Walker’s examination determined that Trasylol patients have an increased risk of death and renal failure.

After addressing the issues with Trasylol in 2006, the FDA requested that the drug be removed from the market in November 2007. This request was made shortly after a study in Canada had to be canceled due to Trasylol patients dying rapidly. Approximately 1,000 patients died per month from complications associated with Trasylol from the time of the FDA’s meeting in 2006 until their decision that the drug should be withdrawn in late 2007.

Some states protect those suffering from debilitating renal failure, complications from stroke, or families enduring the wrongful death of a loved one, due to Trasylol. If you or someone you care about has suffered serious side effects due to Trasylol, an Illinois personal injury lawyer can help you obtain the compensation that you deserve. The time allowed to file a Trasylol claim is limited, which is why it is crucial to act quickly in contacting an attorney with the experience that you need in pharmaceutical litigation.

Bayer Trasylol Injury Liability

Reports have shown that Bayer knew of Trasylol health risks as early as the 1980s, yet still continued manufacturing and marketing the drug. Even though Trasylol has been approved by the FDA for heart surgery patients with a high risk of bleeding, since these patients already have vulnerable health, patients were more at risk of suffering renal failure and requiring dialysis after taking the medication. A top heart surgeon in the United States, Dr. Nicholas Kouchoukos, supports the claim that most patients endured renal failure, permanent debilitating kidney function, and the increased risk of heart attack and stroke.

Bayer’s recurring failure to warn the public of the potential risks of Trasylol make them responsible for the effects that this defective drug has imposed on trusting patients. A patient may not be aware that he or she was given Trasylol until life-altering affects have already imposed significant physical, emotional, and financial challenges. Anyone who has undergone heart surgery and since endured renal failure, heart attack, or stroke may want to contact an Illinois personal injury lawyer with experience in pharmaceutical litigation to find out if Trasylol may be to blame.

How Our Lawyers Can Help

Defective drug lawyer E. Ryan Bradley has decades of experience handling these types of lawsuits and many other personal injury and product liability cases. He has investigated Trasylol and have determined the actions of Bayer warrant valid legal claims for injuries caused by this defective drug. Call today to discuss your case for free.

Avandia
Given to patients for the treatment of adult-onset or type 2 diabetes, Avandia is a drug that may not be as safe as its manufacturer would like consumers and physicians to believe. Our Illinois drug injury attorneys are currently investigating Avandia, which may be considered a defective product under some state laws.

Avandia Side Effects

Some patients who have trusted that Avandia would help them, not create additional health problems, have experienced heart attack, liver failure, osteoporosis, and other life-threatening side effects. Those who have endured any of these symptoms or others while or after taking Avandia may want to contact a skilled Illinois personal injury lawyer with experience in defective drug litigation.

Avandia Heart Attacks

Heart attack and heart failure is the most frequently seen, and potentially deadly, side effect of Avandia. The New England Journal of Medicine published the analysis of 42 studies involving 14,000 patients that revealed that those taking Avandia were 43% more prone to suffering a heart attack. Some patients who have endured a heart attack because of Avandia experienced symptoms of high blood pressure, swollen extremities, shortness of breath, and weight gain.

Avandia Liver Failure

Several unassuming patients have died or needed a liver transplant due to Avandia adversely affecting liver function. Patietns who have experienced liver failure linked to Avanida often suffered serious symptoms, including yellowing of the skin (jaundice), stomach pain, nausea, and fatigue. Anyone taking Avandia should monitor the functioning of their liver very closely to avoid the repercussions of liver failure.

Avandia Illinois Injury Claims

Defective drug cases should not be handled by just any attorney. If you or someone you care about has endured serious side effects from taking Avandia, it is critical to get in touch with an Illinois personal injury lawyer with experience in defective drug litigation. Please get in touch with personal injury lawyer E. Ryan Bradley about your case at no cost to you.